Conclusions
• • Study with (RGD)4-IF750 integrin probe showed tumor targeting and fast clearance
following intravenous injection. Tumor targeting with 2-DG-IF750: Female C57 BL/6 albino mice were s.c. injected with 1 million LL2-luc cells. At 2-3 weeks, mice were i.v. injected with 2-DG-IF750 probe (10 nmol/mouse) and imaged with IVIS Spectrum at indicated time points using 745nm excitation and 800 nm emission filter set.
• • Targeting of the Cox2 expressing tumor cells was demonstrated both in vitro and
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Tumor targeting with (RGD)4-IF750:
Female Nu/Nu mice were s.c. injected with 3 million PC3M-luc2 cells. At day26, mice were i.v. injected with (RDG)4-IF750 probe (2 nmol/mouse) and imaged with IVIS Spectrum at indicated time points using 745nm excitation and 800 nm emission filter set.
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